Gene expression pathways of high grade localized prostate cancer.
- Published in:
- Prostate, 2011, v. 71, n. 14, p. 1568, doi. 10.1002/pros.21373
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2011 AND VI 71 AND IP 14
Results: 12
1
2
SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer.
- Published in:
- Prostate, 2011, v. 71, n. 14, p. 1559, doi. 10.1002/pros.21372
- By:
- Publication type:
- Article
3
High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate.
- Published in:
- Prostate, 2011, v. 71, n. 14, p. 1499, doi. 10.1002/pros.21365
- By:
- Publication type:
- Article
4
A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study.
- Published in:
- Prostate, 2011, v. 71, n. 14, p. 1587, doi. 10.1002/pros.21376
- By:
- Publication type:
- Article
5
Macrophages induce neuroendocrine differentiation of prostate cancer cells via BMP6-IL6 Loop.
- Published in:
- Prostate, 2011, v. 71, n. 14, p. 1525, doi. 10.1002/pros.21369
- By:
- Publication type:
- Article
6
TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer.
- Published in:
- Prostate, 2011, v. 71, n. 14, p. 1548, doi. 10.1002/pros.21371
- By:
- Publication type:
- Article
7
Metabolic syndrome is associated with high grade gleason score when prostate cancer is diagnosed on biopsy.
- Published in:
- Prostate, 2011, v. 71, n. 14, p. 1492, doi. 10.1002/pros.21364
- By:
- Publication type:
- Article
8
hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1).
- Published in:
- Prostate, 2011, v. 71, n. 14, p. 1518, doi. 10.1002/pros.21368
- By:
- Publication type:
- Article
9
Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
- Published in:
- Prostate, 2011, v. 71, n. 14, p. 1538, doi. 10.1002/pros.21370
- By:
- Publication type:
- Article
10
Antitumor effects of carnertinib in castration resistant prostate cancer models: A comparative study with erlotinib.
- Published in:
- Prostate, 2011, v. 71, n. 14, p. 1481, doi. 10.1002/pros.21363
- By:
- Publication type:
- Article
11
VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia.
- Published in:
- Prostate, 2011, v. 71, n. 14, p. 1579, doi. 10.1002/pros.21374
- By:
- Publication type:
- Article
12
Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancer.
- Published in:
- Prostate, 2011, v. 71, n. 14, p. 1510, doi. 10.1002/pros.21367
- By:
- Publication type:
- Article